Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA.
Pediatr Crit Care Med. 2020 Jan;21(1):21-32. doi: 10.1097/PCC.0000000000002126.
To determine risk factors and outcomes associated with delirium in PICU patients.
Retrospective cohort study.
Thirty-two-bed PICU within a tertiary care academic children's hospital.
All children admitted to the PICU March 1, 2014, to October 1, 2016, with at least one Cornell Assessment of Pediatric Delirium score (n = 2,446).
None.
Cornell Assessment of Pediatric Delirium score was performed twice daily as standard of care. We characterized delirium as: 1) presence of greater than or equal to 1 positive score (Cornell Assessment of Pediatric Delirium ≥ 9) and 2) number of days with a positive score. We built multivariable logistic and linear regression models using electronic medical records data. Many patients (n = 1,538; 63%) had a short length of stay (< 48 hr). Compared with patients with length of stay greater than or equal to 48 hours, fewer experienced delirium (30% vs 69%; p < 0.0001). Among 908 patients with length of stay greater than or equal to 48 hours, presence of delirium was independently associated with age less than 2 years old, baseline cognitive dysfunction, primary diagnosis, and duration of mechanical ventilation. Benzodiazepines demonstrated a dose-response effect (odds ratio for presence of delirium, 1.8 [p = 0.03], 3.4 [p < 0.001], and 9.7 [p = 0.005] for < 25th percentile, 25-75th percentile, and > 75th percentile of total dose, vs no exposure). In terms of outcomes, presence of delirium was independently associated with increased ICU length of stay (p < 0.001), whereas days of delirium were independently associated with decline in cognitive function from ICU admission to discharge (odds ratio, 1.06; p < 0.001), increased ICU (p < 0.001), and hospital length of stay (p < 0.001). Neither delirium presence nor total days were independently associated with mortality.
Delirium is common in the PICU, particularly among patients with length of stay greater than or equal to 48 hours. It is independently associated with patient characteristics and PICU exposures, including benzodiazepines. The role of delirium as an independent causal factor in patient outcome requires further investigation.
确定儿科重症监护病房(PICU)患者发生谵妄的相关风险因素和结局。
回顾性队列研究。
一家三级儿童专科医院的 32 床 PICU。
2014 年 3 月 1 日至 2016 年 10 月 1 日期间至少接受过一次康奈尔儿科谵妄评估量表(Cornell Assessment of Pediatric Delirium,CAPD)评分的所有 PICU 入院患儿(n=2446)。
无。
采用 CAPD 量表每日两次进行评估,作为标准护理。我们将谵妄定义为:1)存在≥1 个阳性评分(CAPD≥9);2)出现阳性评分的天数。我们使用电子病历数据构建了多变量逻辑回归和线性回归模型。许多患者(n=1538;63%)的住院时间较短(<48 小时)。与住院时间≥48 小时的患者相比,经历谵妄的患者比例较低(30% vs 69%;p<0.0001)。在 908 名住院时间≥48 小时的患者中,谵妄的发生与年龄<2 岁、基线认知功能障碍、主要诊断和机械通气时间有关。苯二氮䓬类药物显示出剂量反应效应(存在谵妄的比值比,1.8[ p=0.03]、3.4[ p<0.001]和 9.7[ p=0.005],<25%、25-75%和>75%总剂量与无暴露相比)。就结局而言,谵妄的发生与 ICU 住院时间延长独立相关(p<0.001),而谵妄天数与 ICU 入院至出院时认知功能下降独立相关(比值比,1.06;p<0.001)、ICU(p<0.001)和医院住院时间延长(p<0.001)有关。谵妄的发生和总天数均与死亡率无独立相关性。
谵妄在 PICU 中很常见,尤其是在住院时间≥48 小时的患者中。它与患者特征和 PICU 暴露有关,包括苯二氮䓬类药物。谵妄作为患者结局的独立因果因素的作用需要进一步研究。